Single Escalating Dose Pilot Trial of Canakinumab (ILARIS®) in Duchenne Muscular Dystrophy
Clinical trial NCT03936894 · UNKNOWN
Trial details
- NCT number
- NCT03936894
- Sponsor
- Children's National Research Institute
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2024-04-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.